MarketPulse

stock liquidation

2 articles
The Motley FoolThe Motley Fool··Jonathan Ponciano

Boone Capital Exits 372% Biotech Winner to Chase Emerging Clinical Plays

Boone Capital liquidates entire $13.57M Cogent Biosciences stake despite 372% gain, reallocating to earlier-stage biotech plays like TYRA. Strategic rebalancing in volatile sector.
MDTTYRAIONSCOGTBMRN+2biotechclinical-stage
The Motley FoolThe Motley Fool··Dave Kovaleski

Major Asset Manager Exits $18M Hims & Hers Position Ahead of Novo Nordisk Reconciliation

BLKBRD Asset Management fully exits $18M Hims & Hers position in Q4 2025, just before company reconciles with Novo Nordisk.
NVDAGOOGGOOGLNVOHIMSpartnershipweight loss drugs